Chemomab Therapeutics (CMMB) Stock Chart & Stock Price History $1.12 -0.04 (-3.45%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$1.13 +0.01 (+0.80%) As of 04/17/2025 04:03 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Chemomab Therapeutics Stock Price Performance 5 Day Performance-5.12%1 Month Performance-17.04%3 Month Performance-47.66%6 Month Performance-28.66%Year-To-Date Performance-38.12%1 Year Performance+64.71% Receive CMMB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Chemomab Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address CMMB Stock Chart for Saturday, April, 19, 2025 CMMB Chart by TradingView Chemomab Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/18/2025$1.12$1.12$1.19$1.1043,085 shs$16.08 million04/17/2025$1.16$1.12-3.45%$1.19$1.1043,085 shs$16.08 million04/16/2025$1.21$1.16-4.13%$1.22$1.1417,396 shs$16.66 million04/15/2025$1.18$1.21+2.50%$1.25$1.1451,318 shs$17.37 million04/14/2025$1.07$1.18+10.67%$1.19$1.0879,342 shs$16.95 million04/11/2025$0.94$1.07+13.48%$1.08$0.9690,248 shs$15.32 million04/10/2025$0.98$0.94-4.08%$1.01$0.8995,637 shs$13.50 million04/09/2025$0.96$0.98+2.08%$1.11$0.92169,153 shs$14.07 million04/09/2025$0.96$0.98+2.08%$1.11$0.92169,153 shs$14.07 million04/08/2025$1.02$0.96-5.88%$1.09$0.95144,819 shs$13.79 million Get the Latest News and Ratings for CMMB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Chemomab Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/08/2025$1.02$0.96-5.88%$1.09$0.95144,819 shs$13.79 million04/07/2025$1.05$1.02-2.86%$1.10$0.95137,883 shs$14.65 million04/04/2025$1.07$1.05-1.87%$1.07$1.0085,646 shs$15.08 million04/03/2025$1.13$1.07-5.31%$1.12$1.0694,110 shs$15.36 million04/02/2025$1.04$1.13+8.65%$1.25$1.03196,471 shs$16.23 million04/01/2025$1.09$1.04-4.59%$1.07$1.01111,757 shs$14.93 million03/31/2025$1.13$1.09-3.54%$1.11$0.92306,920 shs$15.65 million03/28/2025$1.10$1.13+2.73%$1.14$1.0798,410 shs$16.23 million03/27/2025$1.16$1.10-5.17%$1.35$0.991.20 million shs$15.80 million03/26/2025$1.14$1.16+1.75%$1.22$1.07143,387 shs$16.66 million03/25/2025$1.24$1.14-8.06%$1.24$1.12117,814 shs$16.37 million03/24/2025$1.28$1.24-3.13%$1.28$1.2093,840 shs$17.81 million03/21/2025$1.35$1.28-5.19%$1.30$1.2564,861 shs$18.38 million03/20/2025$1.35$1.35$1.38$1.2775,231 shs$19.39 million03/19/2025$1.44$1.35-6.25%$1.45$1.3089,268 shs$19.39 million03/18/2025$1.50$1.44-4.00%$1.49$1.4255,579 shs$20.68 million Related Companies CABA Stock Chart INZY Stock Chart PYRGF Stock Chart ASRT Stock Chart UNCY Stock Chart CNTX Stock Chart QNCX Stock Chart JSPR Stock Chart MGX Stock Chart MDCX Stock Chart Receive CMMB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Chemomab Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CMMB) was last updated on 4/19/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Chemomab Therapeutics Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Chemomab Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
